Skip to main content

Update on Neuroimaging Techniques to Detect Activity and Progression in MS: The Role of Novel Markers for Chronic Active Inflammation (PRLs, SELs)

Prof. Celia Oreja-Guevara talks about Update on Neuroimaging Techniques to Detect Activity and Progression in MS: The Role of Novel Markers for Chronic Active Inflammation (PRLs, SELs) at ParadigMS Pre-MENACTRIMS Symposium, Abu Dhabi, Dec 7, 2023.

•The central vein sign could be used for differential diagnosis.

•PRLs appear in the early stages and are more common in inflammatory stages.

•PRLs are related to more aggressive disease

•Brain atrophy assessed could help us to assess progression

•Smouldering MS and progressive MS can be imaged using classic and novel techniques

•SELs are related to progressive phases of the disease

BIOGRAPHY

CELIA OREJA-GUEVARA

Prof. Celia Oreja-Guevara is Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid and Professor of Neurology at the University Complutense, Madrid, Spain.

After receiving her MD from the University Complutense, Madrid, Professor Oreja-Guevara completed a PhD in neuroimmunology at the Max-Planck-Institute for Neurobiology, University of Munich, Munich (Germany). She then went on to complete a residency in the Department of Neurology at the University of Bochum, Bochum (Germany) and a postdoctoral fellowship in neuroimaging at the University Hospital San Raffaele, Milan (Italy). She has also held posts at the University of Düsseldorf (Germany),Hospital de Fuenlabrada and at the University Hospital La Paz, both in Madrid.

Professor Oreja-Guevara’s research interests centre on family planning, menopause, clinical and neuroimaging correlations in MS and the use of optical coherence tomography. Neuromyelitis optica (NMO) is among her other therapy areas of interest, and Professor Oreja-Guevara is actively involved in the evaluation of new drugs for the treatment of MS and NMO. As an investigator, she has participated in a number of MS clinical trials and currently heads Paradigms, an independent and non-profit international group of Multiple Sclerosis experts. Currently, Professor Oreja-Guevara is an expert for the Spanish Medicines Agency and for the Scientific Advisory Group on Neurology of the European Medicines Agency.


Media

Details

  • Directors

    ParadigMS Foundation
  • Author(s)

    Celia Oreja-Guevara
  • Country

    Spain
  • Release Date

    December 21, 2023
  • Views


FAQs

Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.